HIGHLIGHTS
- who: Lykke Larsen and collaborators from the Department of Infectious Diseases, Odense University Hospital, Odense, Denmark have published the research: Durability of Antibody Response after Primary Pneumococcal Double-Dose Prime-Boost Vaccination in Adult Kidney Transplant Recipients and Candidates: 18-Month Follow-Up in a Non-Blinded, Randomised Clinical Trial, in the Journal: Vaccines 2022, 10, x FOR PEER REVIEW of /2022/
- what: Nine participants were excluded afterwards as they were not available for the week 96 follow-up due to the following reasons: withdrawal of consent (n=4), death (n=4), or dropout (n . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.